Answer
Belumosudil mesilate (Rezurock) is contraindicated during pregnancy as a precaution because animal findings and its mechanism indicate potential foetal harm, with maternal and/or foetal toxicity occurring below the recommended human dose, and no data exist in pregnant women.
Sources for this answer
- REZUROCK 200 mg film-coated tablets.SANOFI · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 8Document updated
Sources checked